Document Details
Form
Filing Date
Feb 24, 2023
Document Date
Feb 23, 2023
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Neurocrine Biosciences
Issuer
NEUROCRINE BIOSCIENCES INC
Filer
NEUROCRINE BIOSCIENCES INC